Bronchiolitis in a rheumatoid arthritis patient receiving auranofin
A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its bei...
Gespeichert in:
| Veröffentlicht in: | Arthritis and rheumatism 1986-04, Vol.29 (4), p.556-559 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 559 |
|---|---|
| container_issue | 4 |
| container_start_page | 556 |
| container_title | Arthritis and rheumatism |
| container_volume | 29 |
| creator | O'Duffy, J. Desmond Luthra, Harvinder S. Unni, K. Krishnan Hyatt, Robert E. |
| description | A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its being related to the auranofin therapy. |
| doi_str_mv | 10.1002/art.1780290415 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_art_1780290415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ART1780290415</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4355-5b9fcdf7c8f5b37a170c0490ff82008e6ef2382c22f9c79bae93b95150d38ac33</originalsourceid><addsrcrecordid>eNqFkM1LxDAQxYMoa129ehP6D7ROMs02Oa6LX7AgyHouaZrYSL9IW2X_e6td1JunYXjzfsx7hFxSiCkAu1Z-iGkqgElIKD8iAeVMRkCRHpMAAJIIuaSn5Kzv36aVIccFWSAIvhIYkM2NbxtdurZyg-tD14Qq9KUZazW0rggneum_lU4NzjRD6I027t01r6EavWpa65pzcmJV1ZuLw1ySl7vb3eYh2j7dP27W20gnyHnEc2l1YVMtLM8xVTQFDYkEawUDEGZlLEPBNGNW6lTmykjMJaccChRKIy5JPHO1b_veG5t13tXK7zMK2VcZ2fRu9lvGZLiaDd2Y16b4OT-kn3Q56x-uMvt_aNn6efeH_Qn8X2wF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bronchiolitis in a rheumatoid arthritis patient receiving auranofin</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>O'Duffy, J. Desmond ; Luthra, Harvinder S. ; Unni, K. Krishnan ; Hyatt, Robert E.</creator><creatorcontrib>O'Duffy, J. Desmond ; Luthra, Harvinder S. ; Unni, K. Krishnan ; Hyatt, Robert E.</creatorcontrib><description>A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its being related to the auranofin therapy.</description><identifier>ISSN: 0004-3591</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/art.1780290415</identifier><identifier>PMID: 3085683</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adult ; Arthritis, Rheumatoid - drug therapy ; Auranofin ; Aurothioglucose - adverse effects ; Aurothioglucose - analogs & derivatives ; Aurothioglucose - therapeutic use ; Bronchitis - chemically induced ; Female ; Gold - analogs & derivatives ; Humans</subject><ispartof>Arthritis and rheumatism, 1986-04, Vol.29 (4), p.556-559</ispartof><rights>Copyright © 1986 American College of Rheumatology</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4355-5b9fcdf7c8f5b37a170c0490ff82008e6ef2382c22f9c79bae93b95150d38ac33</citedby><cites>FETCH-LOGICAL-c4355-5b9fcdf7c8f5b37a170c0490ff82008e6ef2382c22f9c79bae93b95150d38ac33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.1780290415$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.1780290415$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3085683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Duffy, J. Desmond</creatorcontrib><creatorcontrib>Luthra, Harvinder S.</creatorcontrib><creatorcontrib>Unni, K. Krishnan</creatorcontrib><creatorcontrib>Hyatt, Robert E.</creatorcontrib><title>Bronchiolitis in a rheumatoid arthritis patient receiving auranofin</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its being related to the auranofin therapy.</description><subject>Adult</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Auranofin</subject><subject>Aurothioglucose - adverse effects</subject><subject>Aurothioglucose - analogs & derivatives</subject><subject>Aurothioglucose - therapeutic use</subject><subject>Bronchitis - chemically induced</subject><subject>Female</subject><subject>Gold - analogs & derivatives</subject><subject>Humans</subject><issn>0004-3591</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1LxDAQxYMoa129ehP6D7ROMs02Oa6LX7AgyHouaZrYSL9IW2X_e6td1JunYXjzfsx7hFxSiCkAu1Z-iGkqgElIKD8iAeVMRkCRHpMAAJIIuaSn5Kzv36aVIccFWSAIvhIYkM2NbxtdurZyg-tD14Qq9KUZazW0rggneum_lU4NzjRD6I027t01r6EavWpa65pzcmJV1ZuLw1ySl7vb3eYh2j7dP27W20gnyHnEc2l1YVMtLM8xVTQFDYkEawUDEGZlLEPBNGNW6lTmykjMJaccChRKIy5JPHO1b_veG5t13tXK7zMK2VcZ2fRu9lvGZLiaDd2Y16b4OT-kn3Q56x-uMvt_aNn6efeH_Qn8X2wF</recordid><startdate>198604</startdate><enddate>198604</enddate><creator>O'Duffy, J. Desmond</creator><creator>Luthra, Harvinder S.</creator><creator>Unni, K. Krishnan</creator><creator>Hyatt, Robert E.</creator><general>John Wiley & Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198604</creationdate><title>Bronchiolitis in a rheumatoid arthritis patient receiving auranofin</title><author>O'Duffy, J. Desmond ; Luthra, Harvinder S. ; Unni, K. Krishnan ; Hyatt, Robert E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4355-5b9fcdf7c8f5b37a170c0490ff82008e6ef2382c22f9c79bae93b95150d38ac33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adult</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Auranofin</topic><topic>Aurothioglucose - adverse effects</topic><topic>Aurothioglucose - analogs & derivatives</topic><topic>Aurothioglucose - therapeutic use</topic><topic>Bronchitis - chemically induced</topic><topic>Female</topic><topic>Gold - analogs & derivatives</topic><topic>Humans</topic><toplevel>online_resources</toplevel><creatorcontrib>O'Duffy, J. Desmond</creatorcontrib><creatorcontrib>Luthra, Harvinder S.</creatorcontrib><creatorcontrib>Unni, K. Krishnan</creatorcontrib><creatorcontrib>Hyatt, Robert E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Duffy, J. Desmond</au><au>Luthra, Harvinder S.</au><au>Unni, K. Krishnan</au><au>Hyatt, Robert E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchiolitis in a rheumatoid arthritis patient receiving auranofin</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>1986-04</date><risdate>1986</risdate><volume>29</volume><issue>4</issue><spage>556</spage><epage>559</epage><pages>556-559</pages><issn>0004-3591</issn><eissn>1529-0131</eissn><abstract>A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its being related to the auranofin therapy.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>3085683</pmid><doi>10.1002/art.1780290415</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0004-3591 |
| ispartof | Arthritis and rheumatism, 1986-04, Vol.29 (4), p.556-559 |
| issn | 0004-3591 1529-0131 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_art_1780290415 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
| subjects | Adult Arthritis, Rheumatoid - drug therapy Auranofin Aurothioglucose - adverse effects Aurothioglucose - analogs & derivatives Aurothioglucose - therapeutic use Bronchitis - chemically induced Female Gold - analogs & derivatives Humans |
| title | Bronchiolitis in a rheumatoid arthritis patient receiving auranofin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A30%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchiolitis%20in%20a%20rheumatoid%20arthritis%20patient%20receiving%20auranofin&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=O'Duffy,%20J.%20Desmond&rft.date=1986-04&rft.volume=29&rft.issue=4&rft.spage=556&rft.epage=559&rft.pages=556-559&rft.issn=0004-3591&rft.eissn=1529-0131&rft_id=info:doi/10.1002/art.1780290415&rft_dat=%3Cwiley_cross%3EART1780290415%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3085683&rfr_iscdi=true |